NAVI
52
2
JCI
46
2
LRCX
45
-7
TMO
54
-2
WEC
33
5
IP
51
3
DNB
20
2
UPS
45
2
T
36
4
VZ
25
3
SLG
69
-4
AAP
35
6
CNX
65
-3
WMT
60
-2
TROW
48
-3
NTAP
60
-4
CSCO
53
2
CPB
47
2
DG
32
2
GM
60
11
NAVI
52
2
JCI
46
2
LRCX
45
-7
TMO
54
-2
WEC
33
5
IP
51
3
DNB
20
2
UPS
45
2
T
36
4
VZ
25
3
SLG
69
-4
AAP
35
6
CNX
65
-3
WMT
60
-2
TROW
48
-3
NTAP
60
-4
CSCO
53
2
CPB
47
2
DG
32
2
GM
60
11
Financhill
Back

Clearfield 10K Form

Sell
45

CLFD
Clearfield

Last Price:
28.34
Seasonality Move:
7.03%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CLFD News And Ratings

See the #1 stock for the next 7 days that we like better than CLFD

CLFD Financial Statistics

Sales & Book Value

Annual Sales: $268.72M
Cash Flow: $5.42M
Price / Cash Flow: 23.75
Annual Sales: $20.09
Price / Book: 1.39

Profitability

EPS (TTM): 0.81000
Net Income (TTM): $13.01M
Gross Margin: $85.28M
Return on Equity: 4.26%
Return on Assets: 3.69%

Clearfield Earnings Forecast

Key Clearfield Financial Ratios

  • The Gross Profit Margin over the past 35 years for CLFD is 31.74%.
  • The Selling, General & Administrative Expenses for CLFD have been equal to 17.86% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 2.71% of Operating Income.
  • The Net Earning history of CLFD is 12.11% of Total Revenues.
  • Per Share Earnings over the last 34 years have been positive in 19 years.

Clearfield Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Communications Equipment
Sector: Information Technology
Current Symbol: CLFD
CUSIP: 18482P
Website: seeclearfield.com

Debt

Debt-to-Equity Ratio: 0.02
Current Ratio: 11.09
Quick Ratio: 7.22

Price-to-Earnings

Trailing P/E Ratio: 13.03
Forward P/E Ratio: 15.2

CLFD Technical Analysis vs Fundamental Analysis

Sell
45
Clearfield (CLFD) is a Sell

Is Clearfield a Buy or a Sell?

  • Clearfield stock is rated a Sell
    The current Clearfield [CLFD] share price is $28.27. The Score for CLFD is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.